The Impact of Rosiglitazone on Regression of Atherosclerosis

NCT00166803 · clinicaltrials.gov ↗

NA

Phase

SUSPENDED

Status

60

Enrollment

OTHER

Sponsor class

Stopped no fund

Conditions

Diabetes Mellitus, Atherosclerosis

Interventions

DRUG: Rosiglitazone

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]